Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples

American Journal of Geriatric Psychiatry

Volumn 19, Issue 3, 2011, Pages 274-283

  Schneider, Gudrun ^a   Nienhaus, Kathrin ^a   Gromoll, Jörg ^a   Heuft, Gereon ^a   Nieschlag, Eberhard ^a   Zitzmann, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aging male; androgen receptor polymorphism; CAG repeats; minor and major depression; testosterone

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ARTICLE; DEPRESSION; ESTRADIOL BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; SCORING SYSTEM; SYMPTOM; TESTOSTERONE BLOOD LEVEL;

EID: 79952103634     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181e70c22     Document Type: Article

References (40)

1. Cho HJ, Lavretsky H, Olmstead R, et al: Prior depression history and deterioration of physical health in community-dwelling older adults-a prospective cohort study. AmJ Geriatr Psychiatry 2010; 18:442-451 .
2. Becker MA, Boaz TL, Andel R, et al: Predictors of preventable nursing home hospitalizations: the role of mental disorders and dementia. Am J Geriatr Psychiatry 2010; 18: 475-479 .
3. Panza F, Frisardi V, Capurso C, et al: Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry; 2010; 18:98-116 .
4. McGuire LC, Strine TW, Allen RS, et al: The Patient Health Questionnaire 8: current depressive symptoms among U.S. older adults, 2006 Behavioral Risk Factor Surveillance System. Am J Geriatr Psychiatry 2009; 17:324-334 .
5. Turvey CL, Schultz SK, Beglinger L, et al: A longitudinal community-based study of chronic illness, cognitive and physical function, and depression. Am J Geriatr Psychiatry 2009; 17: 632-641 .
6. Vink D, Aartsen MJ, Comijs HC, et al: Onset of anxiety and depression in the aging population: comparison of risk factors in a 9-year prospective study. Am J Geriatr Psychiatry 2009; 17:642-652 .
7. Canuto A, Giannakopoulos P, Meiler-Mititelu C, et al: Personality traits influence clinical outcome in day hospital-treated elderly depressed patients. Am J Geriatr Psychiatry 2009; 17: 335-343 .
8. Seidman SN, Walsh BT: Testosterone and depression in aging men. Am J Geriatr Psychiatry 1999; 7:18-33 . (Pubitemid 29029826)
9. Basar MM, Aydin G, Mert HC, et al: Relationship between serum sex steroids and aging male symptoms score and international index of erectile function. Urology 2005; 66:597-601 . (Pubitemid 41242331)
10. Seidman SN, Araujo AB, Roose SP, et al: Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry 2002; 159:456-459 . (Pubitemid 34184742)
11. McIntyre RS, Mancini D, Eisfeld BS, et al: Calculated bioavailable testosterone levels and depression in middle aged men. Psychoneuroendocrinology 2006; 31:1029-1035 . (Pubitemid 44485353)
12. Shores MM, Moceri VM, Sloan KL, et al: Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry 2005; 66:7-14 .
13. Morsink LF, Vogelzangs N, Nicklas BJ, et al: Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the Health ABC study. Psychoneuroendocrinology 2007; 32:874-883 . (Pubitemid 350086800)
14. Zitzmann M, Faber S, Nieschlag E: Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91:4435-4343 .
15. Almeida OP, Yeap BB, Hankey GJ, et al: Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry 2008; 65:283-289 . (Pubitemid 351342444)
16. Beutel ME, Wiltink J, Hauck EW, et al: Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 2005; 47:749-755 . (Pubitemid 40745339)
17. Gray PB, Singh AB, Woodhouse LJ, et al: Dose-dependent effects of testosterone on sexual function, mood, and visuo- spatial cognition in older men. J Clin Endocrinol Metab 2005; 90:3838-3846 . (Pubitemid 41058141)
18. Perry PJ, Lund BC, Arndt S, et al: Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy. Ann Clin Psychiatry 2001; 13:75-80 . (Pubitemid 32800172)
19. Zitzmann M, DepenbuschM, Gromoll J, et al: Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 2003; 88:2049-2054 . (Pubitemid 36549876)
20. Zitzmann M: Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat Clin Pract Urol 2007; 4:161-166 . (Pubitemid 46416281)
21. Canale D, Caglieresi C, Moschini C, et al: Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin Endocrinol (Oxf) 2005; 63:356-361 . (Pubitemid 41233456)
22. Seidman SN, Araujo AB, Roose SP, et al: Testosterone level, androgen receptor polymorphism, and depressive symptoms in middleaged men. Biol Psychiatry 2001; 50:371-376 . (Pubitemid 32816951)
23. Ḧark̈onen K, Huhtaniemi I, M̈akinen J, et al: The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in aging men. Int J Androl 2003; 26:187-194 . (Pubitemid 36718211)
24. T'Sjoen GG, De Vos S, Goemaere S, et al: Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 2005; 53:636-642 . (Pubitemid 41623486)
25. Huhtaniemi IT, Pye SR, Limer KL, et al, the European Male Ageing Study Group: Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 2009; 94:277-284 .
26. Crabbe P, Bogaert V, De Bacquer D, et al: part of the interindividual variation in serum testosterone levels in healthy men re- flects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab 2007; 92:3604-3610 . (Pubitemid 47435345)
27. Veldhuis JD, Keenan DM, Liu PY, et al: The aging male hypothalamic- pituitary-gonadal axis: pulsatility and feedback. Mol Cell Endocrinol 2009; 299:14-22 .
28. Wu FC, Tajar A, Pye SR, et al, European Male Aging Study Group: Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008; 93: 2737-2745 . (Pubitemid 352008544)
29. Seidman SM: The aging male, androgens, erectile dysfunction, and depression. J Clin Psychiatry 2003; 64:31-37 .
30. Schweiger U, Deutschle M, Weber B, et al: Testosterone, gonadotropine, and cortisol secretion in male patients with major depression. Psychosom Med 1999; 61:292-296 . (Pubitemid 29249785)
31. Schneider G, Nienhaus K, Gromoll J, et al: Aging males' symptoms in relation to the genetically determined androgen receptor CAG polymorphism, sex hormone levels and sample membership. Psychoneuroendocrinology 2009; 35:578-587 .
32. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental-State." A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198 .
33. Spitzer RL, Kroenke K,Williams JB: Validation and utility of a selfreport version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 1999; 282:1737-1744 . (Pubitemid 29533604)
34. L̈owe B, Spitzer RL, Zipfel S, et al. Gesundheitsfragebogen f̈ur Patienten (PHQ-D), zweite Auflage. (Prime MD Patient Health Questionnaire (PHQ)-German version, 2nd ed.). Karlsruhe, Pfizer, 2002 .
35. Martin A, Rief W, Klaiberg A, et al: Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 2006; 28:71-77 . (Pubitemid 41827572)
36. Hahn D, Reuter K, Ḧarter M: Screening for affective and anxiety disorders in medical patients: comparison of the HADS, GHQ-12 and Brief-PHQ. Psychosoc Med 2006; 3: Doc09 .
37. L̈owe B, Spitzer RL, Gr̈afe K, et al: Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78:131-140 . (Pubitemid 38045472)
38. L̈utdke O, Tomasik MJ, Lang F: Participation rate and sample selectivity in age-comparative cross-sectional designs. Z Entwicklungspsychologie und Psychologische Psychologie 2003; 35: 171-180 . (Pubitemid 36837238)
39. Gum AM, King-Kallimanis B, Kohn R: Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Am J Geriatr Psychiatry 2009; 17:769-781 .
40. Colangelo LA, Sharp L, Kopp P, et al: Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study. Psychoneuroendocrinology 2007; 32:951-958. (Pubitemid 350086809)